Nilotinib+AD induction: Clinical Trials

1 trial of Nilotinib+AD induction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Nilotinib+AD induction: new trials by email Literature Review of Nilotinib+AD induction trials Research Report on Nilotinib+AD induction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Nilotinib+AD induction - Chronic Myeloid Leukemia in Myeloid Blast Crisis, Untreated Adult Acute Myeloid Leukemia
Phase 2UnknownUlsan University Hospital462012-09-012016-05-11

Conditions studied

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)

Sponsors

Ulsan University Hospital (1)

Countries

South Korea (1)

Top investigators

Hawk Kim, M.D., Ph.D. (1)